Intuitive Surgical CMO sells 105 shares after exercise

INTUITIVE SURGICAL INC EVP & Chief Medical Officer Myriam Curet exercised options and sold shares in a coordinated transaction.

Rhea-AI Filing Summary

INTUITIVE SURGICAL INC EVP & Chief Medical Officer Myriam Curet exercised options and sold shares in a coordinated transaction. She exercised a non-qualified stock option for 105 shares of common stock at an exercise price of $229.39 per share, then sold the 105 shares of common stock on the same day at an average price of $493.95 per share. The sale was carried out under a pre-arranged Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026, indicating the timing was pre-scheduled. After these transactions, she directly holds no common shares but indirectly holds 409 shares by trust and continues to hold 1,152 option shares, so the sale represents a relatively small portion of her overall equity exposure to the company.

Insider Trade Summary 10b5-1

Exercise and Sale: 105 shares ($28K approx. pre-tax spread)

Exercise and Sale 4 txns

Insider Curet Myriam

Role EVP & Chief Medical Officer

Sold 105 shs ($52K)

Approx. gross sale proceeds $52K

Approx. exercise cost $24K

Approx. pre-tax spread $28K

Type	Security	Shares	Price	Value
Exercise	Non-Qualified Stock Option (right to buy)	105	$0.00	$0.00
Exercise	Common Stock	105	$229.39	$24K
Sale	Common Stock	105	$493.95	$52K
holding	Common Stock	--	--	--

Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 1,152 contracts (Direct); Common Stock — 0 shares (Direct); Common Stock — 409 shares (Indirect, by Trust)

Footnotes (2)

1. F1. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026.
2. F2. 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Intuitive Surgical (ISRG) executive Myriam Curet do in this Form 4?

Executive Myriam Curet exercised options for 105 Intuitive Surgical shares at $229.39, then sold 105 common shares at $493.95. The transactions occurred on March 10, 2026, and were executed under a pre-arranged Rule 10b5-1 trading plan.

Was the ISRG insider trade by Myriam Curet part of a Rule 10b5-1 plan?

Yes, the sale of 105 Intuitive Surgical common shares was executed under a Trading Plan that complies with SEC Rule 10b5-1. The plan is disclosed as expiring on July 29, 2026, indicating the transactions were pre-scheduled rather than opportunistic.

What prices were involved in Myriam Curet’s Intuitive Surgical Form 4 transactions?

Myriam Curet exercised stock options at an exercise price of $229.39 per share for 105 Intuitive Surgical shares, then sold those 105 common shares at $493.95 per share. This reflects an exercise-and-sell pattern on March 10, 2026.

How many Intuitive Surgical shares did Myriam Curet sell and how many does she still hold?

She sold 105 shares of Intuitive Surgical common stock and ended with no directly held common shares. However, she indirectly holds 409 common shares through a trust and retains 1,152 option shares, maintaining substantial overall exposure.

What type of derivative security did Myriam Curet exercise in the ISRG Form 4?

She exercised a Non-Qualified Stock Option covering 105 underlying Intuitive Surgical common shares. After this exercise, 1,152 option shares remained outstanding, and the option is shown with an expiration date of February 27, 2030.

Does the Intuitive Surgical Form 4 show a routine pattern or a major change for Myriam Curet?

The filing shows a routine exercise-and-sell transaction for 105 shares under a Rule 10b5-1 plan. She still holds 409 shares indirectly via a trust and 1,152 option shares, so the sale represents a small part of her total equity position.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/11/2026 - 01:46 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Curet Myriam

(Last) (First) (Middle)

1020 KIFER ROAD

(Street)

SUNNYVALE CA 94086

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INTUITIVE SURGICAL INC [ ISRG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Medical Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		M(1)		105	A	$229.39	105	D
Common Stock	03/10/2026		S(1)		105	D	$493.95	0	D
Common Stock								409	I	by Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$229.39	03/10/2026		M(1)			105	(2)	02/27/2030	Common Stock	105	$0.0	1,152	D

Explanation of Responses:

1. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026.

2. 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

	By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.